Surgical waiting times for ocular and periocular cancer patients in Toronto

Canadian Journal of Ophthalmology

Volumn 42, Issue 6, 2007, Pages 826-831

  Leung, Andrea K ^a   DeAngelis, Dan D ^b,d   Hurwitz, Jeffrey J ^b   Simpson, E Rand ^b   Oestreicher, James H ^b   Ing, Edsel ^b   Hurwitz, Gillian ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Intraocular tumour; Malignancy; Periocular tumour; Surgery; Wait times

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER PATIENT; CANCER REGISTRY; CANCER SURGERY; CYTOREDUCTIVE SURGERY; ENUCLEATION; ERROR; EXCISION; EYE CANCER; EYE SURGERY; EYEBROW; EYELID CANCER; FACE CANCER; FACE SURGERY; FEMALE; GOVERNMENT; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; LACRIMAL GLAND TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; ORBIT CANCER; PATIENT REFERRAL; PERIOCULAR CANCER; PHYSICIAN; PRECANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UVEA MELANOMA;

EID: 38149091008     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-162     Document Type: Article

References (16)

1. Canadian Intergovernmental Conference Secretariat. 2004 First Ministers' Meeting on the Future of Health Care: investments for health and new funding levels - a 10-year plan to strengthen health care. Available at: http://www.scics.gc.ca/cinfo04/800042005_e.pdf. Accessed September 1, 2006.
2. Ontario Ministry of Health and Long-Term Care. Wait times in your area. Available at: http://www.health.gov.on.ca/transformation/wait_times/ public/wt_public_mn.html#. Accessed September 1, 2006.
3. Hatch WV, Trope GE. Waiting times for eye surgery at a Toronto teaching hospital. Can J Ophthalmol 2004;39:31-7.
4. Hanning M, Lundström M. Assessment of the maximum waiting time guarantee for cataract surgery. The case of a Swedish policy. Int J Technol Assess Health Care 1998;14:180-93.
5. Bellan L, Mathen M. The Manitoba Cataract Waiting List Program. CMAJ 2001;164:1177-80.
6. Smith T. Waiting times: monitoring the total postreferral wait. BMJ 1994;309(6954):593-6.
7. Eskelin S, Kivelä T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol 2002;86:333-8.
8. Holden R, Damato BE. Preventable delays in the treatment of intraocular melanoma in the UK. Eye 1996;10(pt 1):127-9.
9. Damato B. Time to treatment of uveal melanoma in the United Kingdom. Eye 2001;15(pt 2):155-8.
10. Sanmartin CA, for the Steering Committee of the Western Canada Waiting List Project. Toward Standard Definitions for Waiting Times. Available at: http://www.wcwl.org/library/published_papers/?id=published_papers.7. Accessed September 1, 2006.
11. Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651-9.
12. Grin JM, Grant-Kels JM, Grin CM, Berke A, Kels BD. Ocular melanomas and melanocytic lesions of the eye. J Am Acad Dermatol 1998;38(5 pt 1):716-30.
13. Valvassori GE, Sabnis SS, Mafee RF, Brown MS, Putterman A. Imaging of orbital lymphoproliferative disorders. Radiol Clin North Am 1999;37:135-50, x-xi.
14. Duvoisin B, Zanella FE, Sievers KW. Imaging of the normal and pathological orbit. Eur Radiol 1998;8:175-88.
15. Ah-Fat FG, Damato BE. Delays in the diagnosis of uveal melanoma and effect on treatment. Eye 1998;12(pt 5):781-2.
16. Allali J, D'Hermies F, Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica 2005;219:57-71.